AnVIL
NHGRI Analysis Visualizationand Informatics Lab-space
searchclose
TwitterYouYubeDiscourseGitHubSlack

Study

arrow_backDatasets

NHLBI TOPMed - NHGRI CCDG: Vanderbilt University BioVU Atrial Fibrillation Genetics Study

CCDGphs001624.v1.p1dbGapdbGap FHIR

Description

Atrial fibrillation (also called AFib or AF) is a quivering or irregular heartbeat (arrhythmia) that can lead to blood clots, stroke, heart failure and other heart-related complications. At least 2.7 million Americans are living with AFib. Individuals with early onset atrial fibrillation (AF) are included in this study of cases from the BioVU sample repository. BioVU is Vanderbilt's biobank of DNA extracted from leftover and otherwise discarded clinical blood specimens. BioVU operates as a consented biorepository; all individuals must sign the BioVU consent form in order to donate future specimens. BioVU subjects are de-identified and linked to the Synthetic Derivative enabling researchers to access genetic data/DNA material as well as dense, longitudinal electronic medical record (EMR) information.

Stats

2Cohorts
6,153Samples
5,109Participants
31.45 TBSize

Summary

Consent CodesHMB-GSO
Diseasesatrial fibrillation
AccessControlled Access
Study DesignCase Set
Data TypesWhole Genome, Exome

Terra Workspaces

This study has been divided into the following workspaces by consent codes and optionally the originating laboratory.

Terra Workspace NameConsent CodeDiseaseAccessStudy DesignData TypeSamplesParticipantsSize (TB)
AnVIL_CCDG_Baylor_CVD_AFib_BioVU_WGSHMB-GSOatrial fibrillationCase SetWhole Genome1,1221,12226.80
AnVIL_CCDG_Broad_CVD_AF_BioVU_HMB_GSO_WESHMB-GSOatrial fibrillationCase SetExome5,0313,9874.65